Login / Signup

Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital.

Muge CevikHugh McGann
Published in: Sexually transmitted infections (2018)
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • antiretroviral therapy
  • hiv aids
  • hiv infected patients
  • cross sectional
  • stem cells
  • human immunodeficiency virus
  • mesenchymal stem cells
  • electronic health record